{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T20:47:30Z","timestamp":1761511650580,"version":"3.30.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2001,4,1]],"date-time":"2001-04-01T00:00:00Z","timestamp":986083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2001,4,1]],"date-time":"2001-04-01T00:00:00Z","timestamp":986083200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2001,4,1]]},"DOI":"10.1038\/sj.bmt.1703006","type":"journal-article","created":{"date-parts":[[2002,9,4]],"date-time":"2002-09-04T15:51:24Z","timestamp":1031154684000},"page":"801-807","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Allogeneic stem cell transplantation reduces disease progression compared to autologous transplantation in patients with multiple myeloma"],"prefix":"10.1038","volume":"27","author":[{"given":"C","family":"Reynolds","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V","family":"Ratanatharathorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Adams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Braun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Silver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Ayash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Carson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Eisbruch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LA","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"McDonagh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Ferrara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Uberti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2001,7,26]]},"reference":[{"key":"BF1703006_CR1","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1200\/JCO.1994.12.4.764","volume":"12","author":"D Cunningham","year":"1994","unstructured":"Cunningham D, Paz-Ares L, Gore ME et al. High-dose melphalan for multiple myeloma: long-term follow-up data J Clin Oncol 1994 12: 764\u2013768","journal-title":"J Clin Oncol"},{"key":"BF1703006_CR2","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1182\/blood.V67.5.1298.1298","volume":"67","author":"B Barlogie","year":"1986","unstructured":"Barlogie B, Hall R, Zander A et al. High-dose melphalan with autologous bone marrow transplantation for multiple myeloma Blood 1986 67: 1298\u20131301","journal-title":"Blood"},{"key":"BF1703006_CR3","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1056\/NEJM199607113350204","volume":"335","author":"M Attal","year":"1996","unstructured":"Attal M, Harousseau JL, Stoppa AM et al. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Francais du Myelome New Engl J Med 1996 335: 91\u201397","journal-title":"New Engl J Med"},{"key":"BF1703006_CR4","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0140-6736(05)76150-X","volume":"353","author":"G Gahrton","year":"1999","unstructured":"Gahrton G . Treatment of multiple myeloma Lancet 1999 353: 85\u201386","journal-title":"Lancet"},{"key":"BF1703006_CR5","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/sj.bmt.1701459","volume":"22","author":"J Mehta","year":"1998","unstructured":"Mehta J, Singhal S . Graft-versus-myeloma Bone Marrow Transplant 1998 22: 835\u2013843","journal-title":"Bone Marrow Transplant"},{"key":"BF1703006_CR6","doi-asserted-by":"crossref","first-page":"4711","DOI":"10.1182\/blood.V88.12.4711.bloodjournal88124711","volume":"88","author":"BB Bjorkstrand","year":"1996","unstructured":"Bjorkstrand BB, Ljungman P, Svensson H et al. Allogeneic bone marrow transplantation versus autologous stem cell transplantation in multiple myeloma: a retrospective case-matched study from the European Group for Blood and Marrow Transplantation Blood 1996 88: 4711\u20134718","journal-title":"Blood"},{"key":"BF1703006_CR7","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1182\/blood.V91.3.756","volume":"91","author":"S Slavin","year":"1998","unstructured":"Slavin S, Nagler A, Naparstek E et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases Blood 1998 91: 756\u2013763","journal-title":"Blood"},{"key":"BF1703006_CR8","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1038\/sj.bmt.1702385","volume":"25","author":"A Bacigalupo","year":"2000","unstructured":"Bacigalupo A . Hematopoietic stem cell transplants after reduced intensity conditioning regimen (RI-HSCT): report of a workshop of the European Group for Blood and Marrow Transplantation (EBMT) Bone Marrow Transplant 2000 25: 803\u2013805","journal-title":"Bone Marrow Transplant"},{"key":"BF1703006_CR9","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/sj.bmt.1701574","volume":"23","author":"HM Lokhorst","year":"1999","unstructured":"Lokhorst HM, Sonneveld P, Cornelissen JJ et al. Induction therapy with vincristine, adriamycin, dexamethasone (VAD) and intermediate-dose melphalan (IDM) followed by autologous or allogeneic stem cell transplantation in newly diagnosed multiple myeloma Bone Marrow Transplant 1999 23: 317\u2013322","journal-title":"Bone Marrow Transplant"},{"key":"BF1703006_CR10","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1097\/00000421-199710000-00005","volume":"20","author":"M Varterasian","year":"1997","unstructured":"Varterasian M, Janakiraman N, Karanes C et al. Transplantation in patients with multiple myeloma: a multicenter comparative analysis of peripheral blood stem cell and allogeneic transplant Am J Clin Oncol 1997 20: 462\u2013466","journal-title":"Am J Clin Oncol"},{"key":"BF1703006_CR11","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1200\/JCO.1996.14.5.1447","volume":"14","author":"WI Bensinger","year":"1996","unstructured":"Bensinger WI, Rowley SD, Demirer T et al. High-dose therapy followed by autologous hematopoietic stem-cell infusion for patients with multiple myeloma J Clin Oncol 1996 14: 1447\u20131456","journal-title":"J Clin Oncol"},{"key":"BF1703006_CR12","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1182\/blood.V88.7.2787.bloodjournal8872787","volume":"88","author":"WI Bensinger","year":"1996","unstructured":"Bensinger WI, Buckner CD, Anasetti C et al. Allogeneic marrow transplantation for multiple myeloma: an analysis of risk factors on outcome Blood 1996 88: 2787\u20132793","journal-title":"Blood"},{"key":"BF1703006_CR13","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1002\/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U","volume":"36","author":"BG Durie","year":"1975","unstructured":"Durie BG, Salmon SE . A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival Cancer 1975 36: 842\u2013854","journal-title":"Cancer"},{"key":"BF1703006_CR14","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1038\/sj.bmt.1700813","volume":"19","author":"JP Uberti","year":"1997","unstructured":"Uberti JP, Silver SM, Adams PT et al. Tacrolimus and methotrexate for the prophylaxis of acute graft-versus-host disease in allogeneic bone marrow transplantation in patients with hematologic malignancies Bone Marrow Transplant 1997 19: 1233\u20131238","journal-title":"Bone Marrow Transplant"},{"key":"BF1703006_CR15","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","volume":"34","author":"DR Cox","year":"1972","unstructured":"Cox DR . Regression models and life-tables J Stat Soc 1972 34: 187\u2013220","journal-title":"J Stat Soc"},{"key":"BF1703006_CR16","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"EL Kaplan","year":"1958","unstructured":"Kaplan EL, Meier P . Nonparametric estimation from incomplete observations J Am Stat Assoc 1958 53: 457\u2013481","journal-title":"J Am Stat Assoc"},{"key":"BF1703006_CR17","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/sj.bmt.1701634","volume":"23","author":"S Kulkarni","year":"1999","unstructured":"Kulkarni S, Powles RL, Treleaven JG et al. Impact of previous high-dose therapy on outcome after allografting for multiple myeloma Bone Marrow Transplant 1999 23: 675\u2013680","journal-title":"Bone Marrow Transplant"},{"key":"BF1703006_CR18","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/sj.bmt.1702167","volume":"25","author":"KR Desikan","year":"2000","unstructured":"Desikan KR, Tricot G, Dhodapkar M et al. Melphalan plus total body irradiation (MEL-TBI) or cyclophosphamide (MEL-CY) as a conditioning regimen with second autotransplant in responding patients with myeloma is inferior compared to historical controls receiving tandem transplants with melphalan alone Bone Marrow Transplant 2000 25: 483\u2013487","journal-title":"Bone Marrow Transplant"},{"key":"BF1703006_CR19","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1038\/sj.bmt.1701182","volume":"21","author":"B Barlogie","year":"1998","unstructured":"Barlogie B, Jagannath S, Naucke S et al. Long-term follow-up after high-dose therapy for high-risk multiple myeloma Bone Marrow Transplant 1998 21: 1101\u20131107","journal-title":"Bone Marrow Transplant"},{"key":"BF1703006_CR20","first-page":"140a","volume":"25","author":"G Gahrton","year":"2000","unstructured":"Gahrton G, Svensson H, Apperly J et al. Progress in allogeneic hematopoietic stem-cell transplantation for multiple myeloma Bone Marrow Transplant 2000 25: (Suppl. 1) 140a","journal-title":"Bone Marrow Transplant"},{"key":"BF1703006_CR21","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1056\/NEJM200101183440303","volume":"344","author":"WI Bensinger","year":"2001","unstructured":"Bensinger WI, Martin PJ, Storer B et al. Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers New Engl J Med 2001 344: 175\u2013181","journal-title":"New Engl J Med"},{"key":"BF1703006_CR22","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/S0140-6736(00)02090-0","volume":"355","author":"R Powles","year":"2000","unstructured":"Powles R, Mehta J, Kulkarni S et al. Allogeneic blood and bone-marrow stem-cell transplantation in haematological malignant diseases: a randomised trial Lancet 2000 355: 1231\u20131237","journal-title":"Lancet"},{"key":"BF1703006_CR23","doi-asserted-by":"publisher","first-page":"3031","DOI":"10.1200\/JCO.2000.18.16.3031","volume":"18","author":"HM Lokhorst","year":"2000","unstructured":"Lokhorst HM, Schattenberg A, Cornelissen JJ et al. Donor lymphocyte infusions for relapsed multiple myeloma after allogeneic stem-cell transplantation: predictive factors for response and long-term outcome J Clin Oncol 2000 18: 3031\u20133037","journal-title":"J Clin Oncol"},{"key":"BF1703006_CR24","doi-asserted-by":"crossref","first-page":"4206","DOI":"10.1182\/blood.V90.10.4206","volume":"90","author":"HM Lokhorst","year":"1997","unstructured":"Lokhorst HM, Schattenberg A, Cornelissen JJ et al. Donor leukocyte infusions are effective in relapsed multiple myeloma after allogeneic bone marrow transplantation Blood 1997 90: 4206\u20134211","journal-title":"Blood"},{"key":"BF1703006_CR25","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1182\/blood.V87.3.1196.bloodjournal8731196","volume":"87","author":"G Tricot","year":"1996","unstructured":"Tricot G, Vesole DH, Jagannath S et al. Graft-versus-myeloma effect: proof of principle Blood 1996 87: 1196\u20131198","journal-title":"Blood"},{"key":"BF1703006_CR26","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/sj.bmt.1701546","volume":"23","author":"R van der Griend","year":"1999","unstructured":"van der Griend R, Verdonck LF, Petersen EJ et al. Donor leukocyte infusions inducing remissions repeatedly in a patient with recurrent multiple myeloma after allogeneic bone marrow transplantation Bone Marrow Transplant 1999 23: 195\u2013197","journal-title":"Bone Marrow Transplant"},{"key":"BF1703006_CR27","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1200\/JCO.2000.18.11.2273","volume":"18","author":"G Martinelli","year":"2000","unstructured":"Martinelli G, Terragna C, Zamagni E et al. Molecular remission after allogeneic or autologous transplantation of hematopoietic stem cells for multiple myeloma J Clin Oncol 2000 18: 2273\u201381","journal-title":"J Clin Oncol"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1703006","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1703006.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1703006.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,7]],"date-time":"2024-12-07T11:04:47Z","timestamp":1733569487000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1703006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,4,1]]},"references-count":27,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2001,4,1]]}},"alternative-id":["BF1703006"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1703006","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"type":"print","value":"0268-3369"},{"type":"electronic","value":"1476-5365"}],"subject":[],"published":{"date-parts":[[2001,4,1]]},"assertion":[{"value":"19 September 2000","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2001","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2001","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}